Community/Retail

An FDA-registered health hub, the platform shows promising early results, including driving patient engagement rates as high as 80%, leading to changes in underlying behaviors affecting medication nonadherence.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

FDA officials said that U.S. District Judge William H. Steele has entered a consent decree of permanent injunction against compounder Medistat RX, LLC, prohibiting the company from manufacturing or distributing products until it complies with appropriate regulations.